Difference between revisions of "Team:Calgary/Attributions"

 
(37 intermediate revisions by 9 users not shown)
Line 1: Line 1:
−
{{Calgary}}
+
{{:Team:Calgary/Layout}}
−
<html>
+
  
 +
<html lang="en">
  
 +
<head>
 +
    <title>Team:Calgary/Attributions - 2018.igem.org</title>
 +
    <!-- CSS -->
 +
    <link rel="stylesheet" href="https://2018.igem.org/Team:Calgary/info_css?action=raw&ctype=text/css">
 +
    <style>
 +
        .info-link {
 +
            padding: 0 !important;
 +
        }
  
 +
        b {
 +
        color: rgb(247, 183, 51);
 +
        }
 +
    </style>
 +
</head>
  
 +
<body>
 +
    <!-- Content -->
 +
    <div class="container maincontent">
 +
        <h1 style="transform: translateY(-50%)" class="infotitle">ATTRIBUTIONS</h1>
 +
        <br>
 +
        <div class="infosection">
 +
            <h3 class="infosubtitle">Accomplishments</h3>
 +
          <p style="text-indent: 0px">The team's accomplishments can be seen below. For more specific details on what each individual team member worked on this summer, see our <a href= "https://2018.igem.org/Team:Calgary/Team">Team Members</a> page.</p>
  
−
<div class="clear"></div>
+
            <p style="text-indent: 0px">Seven different sgRNA candidates were successfully analyzed for CRISPR targeting efficiency, and their relative efficiencies were compared via indel formation rates.</p>
  
 +
          <p style="text-indent: 0px"> Although the results are preliminary, the presence of a single adhered HEK293T cell in the puromycin-selected plate indicates the possibility of a functional CRISPR/Dual-Recombinase system. This result will require more time and sequencing to conclusively confirm, but we are extremely excited about the potential it holds. </p>
  
 +
          <p style="text-indent: 0px">Various chromatin modifying elements have been successfully cloned and sequence-confirmed and are ready for testing in eukaryotic cells. These parts, including a multiple cloning site optimized for dual-recombinase purposes, have been submitted to the registry for the convenience of future teams interested in recombinase.</p>
  
 +
         
 +
<p style="text-indent: 0px">The droplet formation module of our two-step microfluidics system has been prototyped and is in the testing phase, with plans to prototype the droplet electroporation module soon.
 +
            </p>
 +
<p style="text-indent: 0px">Furthermore, our Software Aggregating Research Assistant (SARA) is complete and functional, and available online for the use of future teams. This software will benefit future teams by compiling useful iGEM software for their own purposes.
 +
            </p>
 +
<p style="text-indent: 0px">None of these accomplishments would have been possible without the advice and support of our mentors who have led us along this journey.
  
  
−
 
+
            </p>
−
<div class="column full_size">
+
            <br>
−
<h1>Attributions</h1>
+
            <h3 class="infosubtitle">General Support</h3>
−
<p>This page is your opportunity to explain what parts of your project you did and what was done by technicians, advisers, etc. This requirement is not about literature references - these can and should be displayed throughout your wiki.
+
            <br>
−
</p>
+
            <p style="text-indent: 0px"><b>Dr. Mayi Arcellana-Panlilio:</b> Dr. Mayi Arcellana-Panlilio is the principal investigator for iGEM Calgary, and serves as a team mentor, organizer, and faculty liaison. Dr. Mayi, as we call her, is the glue which holds the Calgary iGEM team together year after year. Her unwavering support, enthusiasm and solid advice has been a pillar for this team to lean on. While she firmly believes in self directedness and allowing students to learn through trial and error, she was instrumental in troubleshooting and assay design. Perhaps most importantly, she supplied the team with endless smiles, love, and cookies.</p>
−
 
+
            <br>
−
<h3> Bronze Medal Criterion #3</h3>
+
            <p style="text-indent: 0px"><b>Dr. Elke Monika Lohmeier-Vogel:</b> Dr. Lohmeier-Vogel was the secondary PI for iGEM Calgary this year, and provided advice and support throughout the summer. Her knowledge of biochemistry was unparallelled during the frequent troubleshooting within the lab, and aided the team to develop solutions to their procedural pitfalls. Dr. Lohmeier-Vogel was a constant source of motivation and encouragement for the team members, supporting them both in and out of the lab.</p>
−
<p> All of the work done in your project must be attributed correctly on this page. You must clearly state the work that was done by the students on your team and note any work that was done by people outside of your team, including the host labs, advisors, instructors, and individuals not on the team roster.  
+
            <br>
−
<br><br>
+
            <p style="text-indent: 0px"><b>Deirdre Lobb:</b> Deirdre Lobb is the lab technician and manager for the iGEM Calgary lab space. She supported the team with material acquisition, providing countless chemicals and equipment throughout the summer. Deirdre also maintained safety and organization within the lab space, ensuring that experiments were conducted in a safe manner and that all materials were stored and handled properly.
−
Please see the <a href="https://2018.igem.org/Judging/Medals">Medals requirements page</a> for more details.</p>
+
            </p>
−
</div>
+
            <br>
−
 
+
            <h3 class="infosubtitle">Gene Integration Support</h3>
−
 
+
            <br>
−
<div class="clear extra_space"></div>
+
          <p style="text-indent: 0px"><b>Dr. Aneal Khan:</b> Dr. Khan's perspective as a medical geneticist, and the connections he made to people working in the area of cell and gene therapy, were invaluable in clarifying our vision of how Snip Equip Flip could be used in a clinical setting.</p>
−
 
+
            <br>
−
 
+
          <p style="text-indent: 0px"><b>Dr. Ken Ito:</b> Dr. Ito's cutting insight allowed us to place Snip Equip Flip within its competitive landscape. In particular, our decision to use wild type Cas9 rather than Cas9 nickase was a direct consequence of his comments.</p>
−
 
+
          <br>
−
<div class="column third_size">
+
          <p style="text-indent: 0px"><b>Dr. Derrick Rancourt:</b> Dr. Rancourt offered his usual, uniquely penetrating insight at several critical stages during the project's development.</p>
−
<h3> What should this page contain?</h3>
+
          <br>
−
 
+
            <p style="text-indent: 0px"><b>Dr. Jonathon Lytton:</b> Dr. Lytton discussed with us transfection methods for HEK293T cells and modification of cells.</p>
−
<ul>
+
            <br>
−
<li>Clearly state what the team accomplished</li>
+
            <p style="text-indent: 0px"><b>Justin Simms:</b> Justin discussed with us about the use of CRISPR and sgRNA design. </p>
−
<li>General Support</li>
+
            <br>
−
<li>Project support and advice</li>
+
            <p style="text-indent: 0px"><b>Iman Al Khatib:</b> Iman discussed with us the use of RNPs and CRISPR, however her work involves mitochondrial DNA, so she introduced us to Tian Zhao. </p>
−
<li>Fundraising help and advice</li>
+
            <br>
−
<li>Lab support</li>
+
            <p style="text-indent: 0px"><b>Tian Zhao:</b> Tian discussed with us HEK cell culturing techniques and various transfection methods in regards directly to CRISPR. He also attended our Faculty Talk.</p>
−
<li>Difficult technique support</li>
+
            <br>
−
<li>Project advisor support</li>
+
            <p style="text-indent: 0px"><b>Dr. Shirin Bonni:</b> Dr. Bonni kindly gave us the HEK cells we worked with and also gave us valuable advice on transfections and transfection controls.</p>
−
<li>Wiki support</li>
+
            <br>
−
<li>Presentation coaching</li>
+
<h3 class="infosubtitle">Gene Maintenance Support</h3>
−
<li>Human Practices support</li>
+
            <br>
−
<li> Thanks and acknowledgements for all other people involved in helping make a successful iGEM team</li>
+
            <p style="text-indent: 0px"><b>Dr. Ray Wang:</b> Dr. Ray Wang, who is a member at the Chen lab at the University of Calgary, provided us with Flp-In™ 293 T-REx cells. These cells will be used in future experiments and characterization of our Chromatin-Modifying Elements.</p>
−
</ul>
+
         
−
</div>
+
            <br>
−
 
+
            <h3 class="infosubtitle">Dry Lab Support</h3>
−
<div class="column third_size">
+
            <br>
−
<p>Tell us if your institution teaches an iGEM or synthetic biology class and when you started your project:</p>
+
          <p style="text-indent: 0px"><b>Michaela Olsakova:</b> Michaela tested our Software Aggregating Research Assistant (SARA) tool for usability and functionality. She also provided advice on wiki creation and feedback on the design and user-friendliness. </p>
−
<ul>
+
            <br>
−
<li>Does your institution teach an iGEM or synthetic biology course?</li>
+
          <p style="text-indent: 0px"><b>Patrick Wu:</b> Patrick presented on wiki design at the North American Kick-Off and provided feedback on the presentation at aGEM. </p>
−
<li>When did you start this course?</li>
+
            <br>
−
<li>Are the syllabus and course materials freely available online?</li>
+
          <p style="text-indent: 0px"><b>Wm. Keith van der Meulen:</b> Keith gave advice on effective wiki design and narrative creation.
−
<li>When did you start your brainstorming?</li>
+
            </p>
−
<li>When did you start in the lab?</li>
+
            <br>
−
<li>When did you start working on  your project?</li>
+
            <h3 class="infosubtitle">Product Design/Modelling Support</h3>
−
</ul>
+
            <br>
−
</div>
+
            <p style="text-indent: 0px"><b>Dr. Colin Dalton:</b> Dr. Dalton has been instrumental in development of the microfluidics sub-project. He has offered us design advice, access to COMSOL Multiphysics, prototyping and measurement equipment, and access to his test labs. Aside from this, he has also provided us with excellent connections and advice on improving our presentation skills.
−
 
+
</p>
−
 
+
            <br>
−
<div class="column third_size">
+
            <p style="text-indent: 0px"><b>Dr. Ebenezer Owusu-Ansah:</b> Dr. Owusu provided us with laser machining of the glass chips for all of our microfluidic devices. He had also provided us with insight into industrial level production and development projects.
−
<div class="highlight decoration_A_full">
+
</p>
−
 
+
            <br>
−
<h3>Inspiration</h3>
+
            <p style="text-indent: 0px"><b>Dr. Milad Azarmanesh:</b> Early on in the summer we met with Dr. Azarmanesh to gain some insight into approaching design and experimental procedures for microfluidic devices. His comments molded our approach to developing this sub-project.
−
<p>Take a look at what other teams have done:</p>
+
</p>
−
<ul>
+
            <br>
−
<li><a href="https://2011.igem.org/Team:Imperial_College_London/Team">2011 Imperial College London</a> (scroll to the bottom)</li>
+
            <h3 class="infosubtitle">Human Practices Support</h3>
−
<li><a href="https://2014.igem.org/Team:Exeter/Attributions">2014 Exeter </a></li>
+
<br>
−
<li><a href="https://2014.igem.org/Team:Melbourne/Attributions">2014 Melbourne </a></li>
+
          <p style="text-indent: 0px"><b>Dr. Walter Glannon:</b> Dr. Glannon, a philosophy professor specializing in bioethics, met with members of the team to discuss the ethics of the project. </p>
−
<li><a href="https://2014.igem.org/Team:Valencia_Biocampus/Attributions">2014 Valencia Biocampus</a></li>
+
            <br>
−
</ul>
+
            <p style="text-indent: 0px"><b>Dr. Ian Lewis:</b> Dr. Lewis met with the team to discuss the potential applications of the project as well as providing direction regarding the narrative. He is the Health Solutions Chair in Translational Health in Metablomics at Alberta Innovates and is an assistant professor at the University of Calgary.</p>
−
</div>
+
            <br>
−
</div>
+
            <p style="text-indent: 0px"><b>Dr. Philip Behman:</b> The team met with Dr. Behman in August to discuss the social implications of our project, specifically from a Christian perspective. Dr. Behman is a spiritual care practitioner and member of the Spiritual Care Advisory Committee at Alberta Health Services.</p>
−
 
+
            <br>
−
 
+
            <p style="text-indent: 0px"><b>Dr. Harjot Singh:</b> Dr. Singh provided feedback from the Sikh perspective as part of the team's meeting with the Spiritual Care Advisory Committee in August. Dr. Singh is a family physician.</p>
−
 
+
            <br>
−
<div class="clear extra_space"></div>
+
            <p style="text-indent: 0px"><b>Fazel Rehman:</b> Fazel is a community member of the Spiritual Care Advisory Committee at Alberta Health Services. He provided a Muslim perspective at our meeting with the committee in August.</p>
−
 
+
<br>
−
<div class="column two_thirds_size">
+
            <p style="text-indent: 0px"><b>Dr. Jaeun Macen:</b> Dr. Macen is a spiritual health practitioner as part of the Spiritual Care Advisory Committee. We met with her and the rest of the committee in August, and she provided a Christian perspective to our discussion.</p>
−
<h3> Why is this page needed? </h3>
+
            </p>
−
<p>The Attribution requirement helps the judges know what you did yourselves and what you had help with. We don't mind if you get help with difficult or complex techniques, but you must report what work your team did and what work was done by others.</p>
+
<br>
−
<p>
+
            <p style="text-indent: 0px"><b>Kerri Kroeker:</b> The team met with Kerri as part of our meeting with the Spiritual Care Advisory Committee. She is a spiritual health practitioner as part of the committee and provided a Christian perspective.</p>
−
For example, you might choose to work with an animal model during your project. Working with animals requires getting a license and applying far in advance to conduct certain experiments in many countries. This is difficult to achieve during the course of a summer, but much easier if you can work with a postdoc or PI who has the right licenses.</p>
+
<br>
−
</div>
+
            <p style="text-indent: 0px"><b>Tracey Staff:</b> Tracey is a spiritual health practitioner as part of the Spiritual Care Advisory Committee. She represented a Christian perspective as part of our meeting with the committee in August.</p>
−
 
+
<br>
−
<div class="column third_size">
+
            <p style="text-indent: 0px"><b>Teresa Bond:</b> The team met with Teresa, a spiritual health practitioner, as part of our meeting with the Spiritual Care Advisory Committee. Teresa provided a Christian perspective to our discussion with the committee.</p>
−
<div class="highlight decoration_B_full">
+
<br>
−
<h3> Can we base our project on a previous one? </h3>
+
            <p style="text-indent: 0px"><b>Anna Majczak:</b> Anna is a high school IB Biology teacher, the team met with her to discuss the implementation of an IBO curriculum addition and lesson plan.</p>
−
<p>Yes! You can have a project based on a previous team, or based on someone else's idea, <b>as long as you state this fact very clearly and give credit for the original project.</b> </p>
+
<br>
−
</div>
+
            <p style="text-indent: 0px"><b>Marija Susnjar:</b> Marija is an IB Coordinator, the team met with her to discuss the implementation of an IBO curriculum addition and lesson plan.</p>
−
</div>
+
      <br>
−
 
+
            <p style="text-indent: 0px"><b>Norman Hounjet:</b> Norman is an IB Coordinator, the team met with him to discuss the implementation of an IBO curriculum addition and lesson plan.</p>
−
 
+
        </div>
 +
    </div>
 +
</body>
  
 
</html>
 
</html>

Latest revision as of 03:34, 18 October 2018

Team:Calgary/Attributions - 2018.igem.org

ATTRIBUTIONS


Accomplishments

The team's accomplishments can be seen below. For more specific details on what each individual team member worked on this summer, see our Team Members page.

Seven different sgRNA candidates were successfully analyzed for CRISPR targeting efficiency, and their relative efficiencies were compared via indel formation rates.

Although the results are preliminary, the presence of a single adhered HEK293T cell in the puromycin-selected plate indicates the possibility of a functional CRISPR/Dual-Recombinase system. This result will require more time and sequencing to conclusively confirm, but we are extremely excited about the potential it holds.

Various chromatin modifying elements have been successfully cloned and sequence-confirmed and are ready for testing in eukaryotic cells. These parts, including a multiple cloning site optimized for dual-recombinase purposes, have been submitted to the registry for the convenience of future teams interested in recombinase.

The droplet formation module of our two-step microfluidics system has been prototyped and is in the testing phase, with plans to prototype the droplet electroporation module soon.

Furthermore, our Software Aggregating Research Assistant (SARA) is complete and functional, and available online for the use of future teams. This software will benefit future teams by compiling useful iGEM software for their own purposes.

None of these accomplishments would have been possible without the advice and support of our mentors who have led us along this journey.


General Support


Dr. Mayi Arcellana-Panlilio: Dr. Mayi Arcellana-Panlilio is the principal investigator for iGEM Calgary, and serves as a team mentor, organizer, and faculty liaison. Dr. Mayi, as we call her, is the glue which holds the Calgary iGEM team together year after year. Her unwavering support, enthusiasm and solid advice has been a pillar for this team to lean on. While she firmly believes in self directedness and allowing students to learn through trial and error, she was instrumental in troubleshooting and assay design. Perhaps most importantly, she supplied the team with endless smiles, love, and cookies.


Dr. Elke Monika Lohmeier-Vogel: Dr. Lohmeier-Vogel was the secondary PI for iGEM Calgary this year, and provided advice and support throughout the summer. Her knowledge of biochemistry was unparallelled during the frequent troubleshooting within the lab, and aided the team to develop solutions to their procedural pitfalls. Dr. Lohmeier-Vogel was a constant source of motivation and encouragement for the team members, supporting them both in and out of the lab.


Deirdre Lobb: Deirdre Lobb is the lab technician and manager for the iGEM Calgary lab space. She supported the team with material acquisition, providing countless chemicals and equipment throughout the summer. Deirdre also maintained safety and organization within the lab space, ensuring that experiments were conducted in a safe manner and that all materials were stored and handled properly.


Gene Integration Support


Dr. Aneal Khan: Dr. Khan's perspective as a medical geneticist, and the connections he made to people working in the area of cell and gene therapy, were invaluable in clarifying our vision of how Snip Equip Flip could be used in a clinical setting.


Dr. Ken Ito: Dr. Ito's cutting insight allowed us to place Snip Equip Flip within its competitive landscape. In particular, our decision to use wild type Cas9 rather than Cas9 nickase was a direct consequence of his comments.


Dr. Derrick Rancourt: Dr. Rancourt offered his usual, uniquely penetrating insight at several critical stages during the project's development.


Dr. Jonathon Lytton: Dr. Lytton discussed with us transfection methods for HEK293T cells and modification of cells.


Justin Simms: Justin discussed with us about the use of CRISPR and sgRNA design.


Iman Al Khatib: Iman discussed with us the use of RNPs and CRISPR, however her work involves mitochondrial DNA, so she introduced us to Tian Zhao.


Tian Zhao: Tian discussed with us HEK cell culturing techniques and various transfection methods in regards directly to CRISPR. He also attended our Faculty Talk.


Dr. Shirin Bonni: Dr. Bonni kindly gave us the HEK cells we worked with and also gave us valuable advice on transfections and transfection controls.


Gene Maintenance Support


Dr. Ray Wang: Dr. Ray Wang, who is a member at the Chen lab at the University of Calgary, provided us with Flp-In™ 293 T-REx cells. These cells will be used in future experiments and characterization of our Chromatin-Modifying Elements.


Dry Lab Support


Michaela Olsakova: Michaela tested our Software Aggregating Research Assistant (SARA) tool for usability and functionality. She also provided advice on wiki creation and feedback on the design and user-friendliness.


Patrick Wu: Patrick presented on wiki design at the North American Kick-Off and provided feedback on the presentation at aGEM.


Wm. Keith van der Meulen: Keith gave advice on effective wiki design and narrative creation.


Product Design/Modelling Support


Dr. Colin Dalton: Dr. Dalton has been instrumental in development of the microfluidics sub-project. He has offered us design advice, access to COMSOL Multiphysics, prototyping and measurement equipment, and access to his test labs. Aside from this, he has also provided us with excellent connections and advice on improving our presentation skills.


Dr. Ebenezer Owusu-Ansah: Dr. Owusu provided us with laser machining of the glass chips for all of our microfluidic devices. He had also provided us with insight into industrial level production and development projects.


Dr. Milad Azarmanesh: Early on in the summer we met with Dr. Azarmanesh to gain some insight into approaching design and experimental procedures for microfluidic devices. His comments molded our approach to developing this sub-project.


Human Practices Support


Dr. Walter Glannon: Dr. Glannon, a philosophy professor specializing in bioethics, met with members of the team to discuss the ethics of the project.


Dr. Ian Lewis: Dr. Lewis met with the team to discuss the potential applications of the project as well as providing direction regarding the narrative. He is the Health Solutions Chair in Translational Health in Metablomics at Alberta Innovates and is an assistant professor at the University of Calgary.


Dr. Philip Behman: The team met with Dr. Behman in August to discuss the social implications of our project, specifically from a Christian perspective. Dr. Behman is a spiritual care practitioner and member of the Spiritual Care Advisory Committee at Alberta Health Services.


Dr. Harjot Singh: Dr. Singh provided feedback from the Sikh perspective as part of the team's meeting with the Spiritual Care Advisory Committee in August. Dr. Singh is a family physician.


Fazel Rehman: Fazel is a community member of the Spiritual Care Advisory Committee at Alberta Health Services. He provided a Muslim perspective at our meeting with the committee in August.


Dr. Jaeun Macen: Dr. Macen is a spiritual health practitioner as part of the Spiritual Care Advisory Committee. We met with her and the rest of the committee in August, and she provided a Christian perspective to our discussion.


Kerri Kroeker: The team met with Kerri as part of our meeting with the Spiritual Care Advisory Committee. She is a spiritual health practitioner as part of the committee and provided a Christian perspective.


Tracey Staff: Tracey is a spiritual health practitioner as part of the Spiritual Care Advisory Committee. She represented a Christian perspective as part of our meeting with the committee in August.


Teresa Bond: The team met with Teresa, a spiritual health practitioner, as part of our meeting with the Spiritual Care Advisory Committee. Teresa provided a Christian perspective to our discussion with the committee.


Anna Majczak: Anna is a high school IB Biology teacher, the team met with her to discuss the implementation of an IBO curriculum addition and lesson plan.


Marija Susnjar: Marija is an IB Coordinator, the team met with her to discuss the implementation of an IBO curriculum addition and lesson plan.


Norman Hounjet: Norman is an IB Coordinator, the team met with him to discuss the implementation of an IBO curriculum addition and lesson plan.